INSANE: 20 - The Real Truth

Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound

Planet Labs shares have fallen more than 60% from 2026 highs despite strong Q2 revenue growth, and analysts' $32.78 consensus price target implies over 90% upside potential.

MarketBeat · Sep 13

As Homeowners' Premiums Surge, This Insurer Is Posting Record Profits

Rising homeowners insurance premiums, driven by climate disasters and higher rebuilding costs, have boosted Allstate's Q2 profits, underwriting income, and stock performance, analysts note.

MarketBeat · Sep 13

Nasdaq’s $100 Million Kraken Bet Prepares It for a Market That Never Closes

Nasdaq invested $100 million in Kraken parent Payward, planning tokenized Nasdaq Equity Tokens by 2027 and licensing surveillance software, while posting strong Q2 earnings and revenue growth.

MarketBeat · Sep 13

Is Nike's Index Demotion a Warning or a Buying Opportunity?

Nike will exit the S&P 100 index this month as shares fall over 40% in 2025, with declining sales, China weakness, and competition weighed against CEO Elliott Hill's turnaround efforts ahead of October earnings.

MarketBeat · Sep 12

American Eagle Goes on Sale: Is It Time to Buy?

American Eagle shares fell after Q2 results despite record revenue, but tariff refunds, growth at Aerie and OFFLINE, a 3% dividend yield, and analyst targets suggest upside potential.

MarketBeat · Sep 12

MarketBeat Week in Review – 09/07 - 09/11

Stocks fell this week on oil prices and Fed rate-hike expectations, though Oracle's earnings underscored AI infrastructure strength. MarketBeat analysts recap top stories on earnings, defense, AI, and other stock opportunities.

MarketBeat · Sep 12

Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model

Block filed with the OCC to form Builders Bank & Trust, N.A., a national trust charter aimed at cutting sponsor-bank fees and unifying compliance for Cash App and Square.

MarketBeat · Sep 11

Kroger’s Textbook Entry for Buy-and-Hold Investors

Kroger stock trades near long-term lows despite resilient Q2 results, steady buybacks, a 2.7% dividend yield, and Moderate Buy analyst ratings with upside potential.

MarketBeat · Sep 11

AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window

AST SpaceMobile seeks an FCC extension for 800 MHz satellite testing as the SDA backs a separate spectrum application, highlighting growing defense interest despite recent earnings misses.

MarketBeat · Sep 11

Amgen Drops 10% on a Trial It Didn't Even Run

AMGN stock fell after Novartis' Pelacarsen trial failed, though Amgen's own Olpasiran and Repatha differ in mechanism and results, and analysts have kept price targets largely intact.

MarketBeat · Sep 11